BioCentury | Nov 30, 2017
Company News
Catalyst, Mosaic partner to develop anti-C3 proteases for dry AMD
...Catalyst Biosciences Inc. (NASDAQ:CBIO) partnered with Mosaic Biosciences Inc. (Boulder, Colo.) to develop Catalyst’s preclinical anti-complement 3 (C3...
...Inc. (NASDAQ:CBIO), South San Francisco, Calif. Mosaic Biosciences Inc., Boulder, Colo. Business: Ophthalmic, Inflammation Jaime De Leon Catalyst Biosciences Inc. Mosaic Biosciences Inc. Complement...
...Inc. (NASDAQ:CBIO), South San Francisco, Calif. Mosaic Biosciences Inc., Boulder, Colo. Business: Ophthalmic, Inflammation Jaime De Leon Catalyst Biosciences Inc. Mosaic Biosciences Inc. Complement...